Skip to content

The six months study of unoprostone eye drop therapy for retinitis pigmentosa

The six months study of unoprostone eye drop therapy for retinitis pigmentosa - The Effect of unoprostone for retinitis pigmentosa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000000592
Enrollment
30
Registered
2007-03-01
Start date
2007-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis Pigmentosa

Interventions

None

Sponsors

Ophthalmology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Informed consent

Exclusion criteria

Exclusion criteria: Bad central visual field sensitivity

Design outcomes

Primary

MeasureTime frame
Micro-perimetry

Countries

Japan

Contacts

Public ContactTakeshi Sugawara

Chiba University Hospital Ophthalmology

takeshis@faculty.chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026